{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:45:53Z","timestamp":1765547153438,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000156","name":"FRQS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bmc.2023.117541","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T11:43:09Z","timestamp":1701862989000},"page":"117541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Discovery of an adjuvant that resensitizes polymyxin B-resistant bacteria"],"prefix":"10.1016","volume":"97","author":[{"given":"Michael","family":"Mahdavi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7083-2513","authenticated-orcid":false,"given":"Brandon L.","family":"Findlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117541_b0005","first-page":"277","article-title":"The Antibiotic Resistance Crisis","volume":"40","author":"Ventola","year":"2015","journal-title":"P T."},{"key":"10.1016\/j.bmc.2023.117541_b0010","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrmicro.2017.75","article-title":"Prediction of antibiotic resistance: time for a new preclinical paradigm?","volume":"15","author":"Sommer","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2023.117541_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2023.117541_b0020","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance-the need for global solutions","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmc.2023.117541_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002184","article-title":"10 Million People Die a Year due to Antimicrobial Resistance by 2050?","volume":"13","author":"de Kraker","year":"2016","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.bmc.2023.117541_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-28188-w","article-title":"Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections","volume":"13","author":"Chung","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2023.117541_b0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1128\/AAC.03774-14","article-title":"Bacterial Resistance to Leucyl-tRNA Synthetase Inhibitor GSK2251052 Develops during Treatment of Complicated Urinary Tract Infections","volume":"59","author":"O\u2019Dwyer","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117541_b0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2023.117541_b0045","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/pro.2889","article-title":"One ring to rule them all: Current trends in combating bacterial resistance to the \u03b2-lactams: Structure-Based Approaches to Overcome \u03b2-Lactam Resistance","volume":"25","author":"King","year":"2016","journal-title":"Protein Sci"},{"year":"2019","series-title":"World Health Organization Model List of Essential Medicines for Children: 7th List 2019","author":"World Health Organization","key":"10.1016\/j.bmc.2023.117541_b0050"},{"key":"10.1016\/j.bmc.2023.117541_b0055","unstructured":"Kane SP. Amoxicillin; Clavulanate, ClinCalc DrugStats Database. Published September 15, 2021. Accessed July 25, 2022. https:\/\/clincalc.com\/DrugStats\/Drugs\/AmoxicillinClavulanate."},{"key":"10.1016\/j.bmc.2023.117541_b0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/eva.12196","article-title":"The fitness costs of antibiotic resistance mutations","volume":"8","author":"Melnyk","year":"2015","journal-title":"Evol Appl"},{"key":"10.1016\/j.bmc.2023.117541_b0065","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41564-018-0164-0","article-title":"Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides","volume":"3","author":"L\u00e1z\u00e1r","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.bmc.2023.117541_b0070","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/s41598-018-34911-9","article-title":"Access to high-impact mutations constrains the evolution of antibiotic resistance in soft agar","volume":"8","author":"Ghaddar","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2023.117541_b0075","doi-asserted-by":"crossref","unstructured":"Backman TWH, Cao Y, Girke T. ChemMine tools: an online service for analyzing and clustering small molecules. Nucleic Acids Res. 2011;39(Web Server issue):W486-491. 10.1093\/nar\/gkr320.","DOI":"10.1093\/nar\/gkr320"},{"key":"10.1016\/j.bmc.2023.117541_b0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0143-7208(96)00022-8","article-title":"Structure and properties of hematein derivatives","volume":"32","author":"Shirai","year":"1996","journal-title":"Dyes Pigm"},{"key":"10.1016\/j.bmc.2023.117541_b0085","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3892\/ijo.2013.2087","article-title":"Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model","volume":"43","author":"Hung","year":"2013","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bmc.2023.117541_b0090","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ptr.1524","article-title":"The antibacterial principle of Caesalpina sappan","volume":"18","author":"Xu","year":"2004","journal-title":"Phytotherapy Res"},{"key":"10.1016\/j.bmc.2023.117541_b0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12906-015-0580-0","article-title":"Antibiotic additive and synergistic action of rutin, morin and quercetin against methicillin resistant Staphylococcus aureus","volume":"15","author":"Amin","year":"2015","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.bmc.2023.117541_b0100","doi-asserted-by":"crossref","unstructured":"Arima H, Ashida H, Danno G ichi. Rutin-enhanced antibacterial activities of flavonoids against Bacillus cereus and Salmonella enteritidis. Biosci Biotechnol Biochem. 2002;66(5):1009-1014. 10.1271\/bbb.66.1009.","DOI":"10.1271\/bbb.66.1009"},{"key":"10.1016\/j.bmc.2023.117541_b0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.micpath.2018.04.007","article-title":"Rutin inhibits quorum sensing, biofilm formation and virulence genes in avian pathogenic Escherichia coli","volume":"119","author":"Peng","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.bmc.2023.117541_b0110","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.bbamem.2013.07.029","article-title":"A structure\u2013activity relationship study of flavonoids as inhibitors of E. coli by membrane interaction effect. Biochimica et Biophysica Acta (BBA) -","volume":"1828","author":"Wu","year":"2013","journal-title":"Biomembranes"},{"key":"10.1016\/j.bmc.2023.117541_b0115","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/BF00937611","article-title":"Structure of ugaferin and some properties of ugamdiol derivatives","volume":"14","author":"Saidkhodzhaev","year":"1978","journal-title":"Chem Nat Compd"},{"key":"10.1016\/j.bmc.2023.117541_b0120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/BF02323307","article-title":"Acetylhaplophyllidine, a new alkaloid from Haplophyllum perforatum","volume":"35","author":"Bessonova","year":"1999","journal-title":"Chem Nat Compd"},{"key":"10.1016\/j.bmc.2023.117541_b0125","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1021\/jm0000057","article-title":"Structure\u2212Function Studies of Polymyxin B Nonapeptide: Implications to Sensitization of Gram-Negative Bacteria","volume":"43","author":"Tsubery","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117541_b0130","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/AAC.44.12.3317-3321.2000","article-title":"Interactions of Bacterial Cationic Peptide Antibiotics with Outer and Cytoplasmic Membranes of Pseudomonas aeruginosa","volume":"44","author":"Zhang","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117541_b0135","article-title":"A Rapid Fluorescence-Based Microplate Assay to Investigate the Interaction of Membrane Active Antimicrobial Peptides with Whole Gram-Positive Bacteria","volume":"9","author":"Boix-Lemonche","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.bmc.2023.117541_b0140","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1099\/00221287-143-8-2531","article-title":"Measurement of cytoplasmic pH of the alkaliphile Bacillus lentus C-125 with a fluorescent pH probe","volume":"143","author":"Aono","year":"1997","journal-title":"Microbiology"},{"key":"10.1016\/j.bmc.2023.117541_b0145","doi-asserted-by":"crossref","first-page":"11561","DOI":"10.1073\/pnas.1608623113","article-title":"Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid II","volume":"113","author":"Cochrane","year":"2016","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2023.117541_b0150","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.diagmicrobio.2016.10.003","article-title":"Antimicrobial susceptibility of 2906 Pseudomonasaeruginosa clinical isolates obtained from patients in Canadian hospitals over a period of 8 years: Results of the Canadian Ward surveillance study (CANWARD), 2008\u20132015","volume":"87","author":"Walkty","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bmc.2023.117541_b0155","doi-asserted-by":"crossref","unstructured":"Zhanel GG, Adam HJ, Baxter MR, et al. 42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance study. J Antimicrob Chemother. 2019;74(Suppl 4):iv5-iv21. 10.1093\/jac\/dkz283.","DOI":"10.1093\/jac\/dkz283"},{"key":"10.1016\/j.bmc.2023.117541_b0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat Protocols."},{"key":"10.1016\/j.bmc.2023.117541_b0165","unstructured":"CLSI. M100 - Performance Standards for Antimicrobial Susceptibility Testing. 32nd Edition. Clinical and Laboratory Standards Institute; 2022. Accessed March 1, 2023. https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m100\/."},{"key":"10.1016\/j.bmc.2023.117541_b0170","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jac\/11.5.427","article-title":"The fractional inhibitory concentration (FIC) index as a measure of synergy","volume":"11","author":"Hall","year":"1983","journal-title":"J Antimicrob Chemother"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:24:00Z","timestamp":1760837040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623003899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":34,"alternative-id":["S0968089623003899"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117541","relation":{},"ISSN":["0968-0896"],"issn-type":[{"type":"print","value":"0968-0896"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of an adjuvant that resensitizes polymyxin B-resistant bacteria","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117541"}}